Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study

BACKGROUND: The purpose of this study was to evaluate the safety and tolerability of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5%, when used for infection prophylaxis following uncomplicated phacoemulsification clear cornea surgery using sutureless corn...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhotra, Ranjan, Gira, Joseph, Berdy, Gregg J, Brusatti, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373231/
https://www.ncbi.nlm.nih.gov/pubmed/22701313
http://dx.doi.org/10.2147/OPTH.S29604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373231/
https://www.ncbi.nlm.nih.gov/pubmed/22701313
http://dx.doi.org/10.2147/OPTH.S29604

Ejemplares similares